Within the past 30 days, our consensus EPS projection remained stagnant. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.īased on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors should also note any recent changes to analyst estimates for Stem, Inc.These recent revisions tend to reflect the evolving nature of short-term business trends. These results would represent year-over-year changes of +27.71% and +212.91%, respectively. STEM's full-year Zacks Consensus Estimates are calling for earnings of -$0.60 per share and revenue of $398.56 million.
Our most recent consensus estimate is calling for quarterly revenue of $89.81 million, up 125.47% from the year-ago period. is projected to report earnings of -$0.15 per share, which would represent no growth from the prior-year quarter. will be looking to display strength as it nears its next earnings release, which is expected to be November 3, 2022. This has lagged the Computer and Technology sector's loss of 5.85% and the S&P 500's loss of 4.82% in that time.
Prior to today's trading, shares of the company had lost 22.02% over the past month. Meanwhile, the Dow gained 2.47%, and the Nasdaq, a tech-heavy index, lost 0.02%. This change lagged the S&P 500's daily gain of 2.37%.
Stem inc stock free#
( STEM Quick Quote STEM - Free Report) closed at $11.59 in the latest trading session, marking a -0.52% move from the prior day.
0 kommentar(er)
